Comparison
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 vs 3q26q28 Deletion Syndrome C6010434
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Fetal Androgens Excess and 3q26q28 Deletion Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
A condition where an XX fetus produces excess male hormones, often from adrenal gland abnormalities, leading to atypical genital development. It is identified at birth. Treatment typically includes hormone therapy and possible surgery.
3q26q28 Deletion Syndrome C6010434
A genetic condition involving deletion of part of chromosome 3q26q28, typically causing developmental delays, growth issues, and multiple congenital differences.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
0-0
3q26q28 Deletion Syndrome C6010434
Variable
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
severe
3q26q28 Deletion Syndrome C6010434
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
Chronic
3q26q28 Deletion Syndrome C6010434
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
No
3q26q28 Deletion Syndrome C6010434
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
reproductive
3q26q28 Deletion Syndrome C6010434
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
endocrine
3q26q28 Deletion Syndrome C6010434
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-fetal-androgens-excess-C5680189 and 3q26q28-deletion-syndrome-C6010434 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 | 3q26q28 Deletion Syndrome C6010434 | Discriminating power |
|---|---|---|---|
| Genital appearance | Atypical genital development may be evident at birth from fetal androgen excess. | Genital differences are not the defining feature in the supplied description. | High |
| Development and growth | Primary pattern is hormonal and genital rather than a multisystem developmental syndrome. | Developmental delay, growth issues, and multiple congenital differences are typical. | High |
| Cause | Excess fetal androgens, often linked to adrenal abnormality, in an XX fetus. | Deletion involving chromosome region 3q26q28. | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 when
Newborn with atypical genitalia and suspected androgen excess
The presentation centers on fetal androgen exposure in a 46,XX fetus.
High
Endocrine evaluation suggests an adrenal source
Adrenal abnormality is a commonly cited mechanism, but the exact cause needs testing.
Moderate
Karyotype is 46,XX without a chromosomal deletion
A normal chromosome complement supports this category over a deletion syndrome.
High
Choose 3q26q28 Deletion Syndrome C6010434 when
Developmental delay with growth concerns and congenital anomalies
This pattern matches the described chromosomal deletion syndrome.
Moderate
Genetic testing shows a 3q26q28 deletion
A confirmed deletion is the defining evidence.
High
Features are multisystem rather than primarily genital-endocrine
The supplied description emphasizes broader congenital effects.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 | 3q26q28 Deletion Syndrome C6010434 | Interpretation |
|---|---|---|---|
| Karyotype or chromosomal microarray | Typically 46,XX without the named deletion. | Deletion involving 3q26q28. | Genetic testing distinguishes the categories; results require specialist interpretation. |
| Endocrine assessment | May show androgen excess; exact cutoffs are not established here. | No specific endocrine pattern is supplied. | Abnormal hormone results support, but do not alone diagnose, the left condition. |
| Developmental and dysmorphology evaluation | Not primarily defined by global developmental delay. | May identify developmental, growth, and congenital differences. | Clinical pattern guides testing but is not diagnostic by itself. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
- Outcome
- Often lifelong endocrine and genital care; exact outcome is not established.
- Factors
- Cause of androgen excess, adrenal status, and timing of care.
3q26q28 Deletion Syndrome C6010434
- Outcome
- Variable course related to developmental and congenital findings.
- Factors
- Deletion extent and affected systems, which are not specified here.
Time frame: From birth or recognition through long-term follow-up.
Diagnosis confirmation, associated anomalies, and access to coordinated care.
Complications comparison
| Complication | Presentation |
|---|---|
| Adrenal or hormonal imbalance | Possible when adrenal disease causes androgen excess; severity varies. Not established from the supplied description. Urgent endocrine assessment is needed if adrenal crisis is suspected. |
| Developmental disability | Not a defining feature in the source description. Developmental delay is described as typical. Support needs depend on individual assessment. |
| Congenital anomalies | Mainly atypical genital development is described. Multiple congenital differences may occur. Organ-specific complications are not specified here. |
Patient education highlights
- HighDifferent causes
One condition involves fetal androgen excess in an XX fetus; the other is a chromosome 3 deletion.
- HighSpecialist care
Endocrine, genetics, and pediatric specialists should interpret results and discuss options.
- MediumIndividual course
Both can be chronic, but outcomes vary and exact prognosis is not established here.